Karyopharm Therapeutics Inc (FRA:25K)
€ 0.5734 -0.0194 (-3.27%) Market Cap: 84.88 Mil Enterprise Value: 143.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 08:45PM GMT
Release Date Price: €7.22 (+10.40%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

Good afternoon, and welcome back to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm. Our next presenting company is Karyopharm Therapeutics, and it's my pleasure to welcome CEO, Richard Paulson, to talk to us a little bit about the company. There's a Q&A session after the presentation. (Operator Instructions)

So with that, Richard, thanks again for sharing some of your time with us this afternoon.

Richard A. Paulson
Karyopharm Therapeutics Inc. - President, CEO & Director

Thank you, Eric, and it's great to see you again. Thanks also to JPMorgan for hosting the event virtually today. Good afternoon, everyone, and thank you for listening. To help keep us synchronized through the presentation, I'll call out the slide numbers as I go.

So before we begin, please turn to Slide 2, and I'd like to remind you that for various remarks we'll make they constitute forward-looking statements, and the actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot